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The Multimodal Imaging Brain Connectivity Analysis (MIBCA) toolbox is a fully auto-
mated all-in-one connectivity analysis toolbox that offers both pre-processing, connec-
tivity, and graph theory analysis of multimodal images such as anatomical, diffusion,
and functional MRI, and PET [1]. In this work, the MIBCA functionalities were used
to study Alzheimer’s Disease in a multimodal MR/PET approach.
Data from 11 healthy subjects and 10 AD patients were obtained from the Alzhei-
mer’s Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu), including
T1-weighted (T1w), Diffusion Tensor Imaging (DTI) data, and 18F-AV-45 (florbetapir)
dynamic PET data from 40-60 min post injection (4x5min). Both MR and PET data
were automatically pre-processed for all subjects using MIBCA. The T1w data was par-
cellated into cortical and subcortical regions-of-interest (ROIs), and the corresponding
thicknesses and volumes were calculated. DTI data was used to compute structural
connectivity matrices based on fibers connecting pairs of ROIs. Lastly, dynamic PET
images were summed, and the Standard Uptake Values calculated for each ROI.
An overall higher uptake of 18F-AV-45, consistent with an increased deposition of
amyloid-Beta, was observed for the AD group. Additionally, patients showed significant
cortical atrophy (thickness and volume) especially in the enthorhinal and temporal
areas, and a significant increase in Mean Diffusivity (MD) in the hippocampus, amyg-
dala and temporal areas, Figure 1. Furthermore, patients showed an overall decrease of
both inter- and intra- hemispherical structural connections (tracts), Figure 2. Finally,
the 3D-graph visualization showed that the structural loss was global and asymmetric,
Figure 3.
This work shows the potential of the MIBCA toolbox for the study of AD, as find-
ings were shown to be in agreement with the literature [2-4]. Here, only structural
changes and beta amyloid accumulation were considered. Yet, MIBCA is further able
to process fMRI and different radiotracers, and combine all the information in order
to provide new insights into AD.
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Figure 1 Group difference Connectrogram. Significant differences between Healthy Subjects and AD
patients are highlighted in color in the inner rings. From outside to inside rings: region-of-interest (ROI),
Standard Uptake Value (18F-AV-45), mean diffusivity, ROI volume, cortical thickness, node degree computed
from structural connectivity.
Figure 2 Group connectivity matrices for Healthy Subjects (upper row), and AD patients (lower row). From
left to right are represented the structural, cortical thickness and cortical volume connectivity matrices.
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